IASLC

Registration is now open for #WCLC26, Sept 12–15 in Seoul 🇰🇷! Join the global thoracic oncology community to explore new science and connect with experts shaping the future of #lungcancer care. 🌟IASLC members receive discounted rates! Learn more and register: wclc.iaslc.org

especially informative episode as a trainee!

How do we get the right molecular answer at the right time for the right patient? 🎙️ In the latest Lung Cancer Considered, host Dr. Narjust Florez conducts mock molecular tumor boards with @MNagasaka and @BRicciutiMD, recorded live at #TTLC26. Tune in: bit.ly/4sGbl9g #LungCancer #LungCancerConsidered

Great start with an amazing inaugural @iaslc Leadership Development Program class from all across the globe kicked off by wonderful presentations by no other than Drs. Kelly and Ben Solomon! We learned among other things that some time you need to step off the clinical conveyor belt to focus on developing additional skills and that career paths are rarely linear. Special thanks to all our mentors sacrificing their precious time to support our class/program- they are clearly ones who lead by example! @chulkimMD @tnewsomdavis @clarissamathias @RielyMD amd terrific co-chairs @drsabita , Marie-Liesse Asselin-Labat and Deebya Mishra

🥇 @ZPiotrowskaMD and @JSabari sparred on whether novel TKIs should take the gold as first-line treatment for EGFR or HER2 exon 20 mutations. Read the highlights from #TTLC26 in ILCN: bit.ly/475Emmq

⚖️ A #TTLC26 debate between Drs. @leahbackhusmd and Gregory Kalemkerian highlights the ongoing divide over surgery in malignant pleural mesothelioma. Read the arguments from both sides in ILCN: ilcn.org/debate-highlig…

Strong peer review strengthens science. The JTO Reviewer Workshop at #WCLC26 offers early-career researchers hands-on insight into how high-quality manuscript review works, directly from journal editors and experts. Apply today: bit.ly/4ljCIDq

What are the biggest debates around antibody-drug conjugates (ADCs) right now? Dr. @NarjustFlorezMD and @Sam_Rosner_ explore the evolving role of ADCs in this new #LungCancerConsidered episode recorded live at #TTLC26. 🎧 Tune in: bit.ly/3Pr75fi #LungCancer

After experiencing personal loss, Sofía Jubany turned her experience into action through the IASLC STARS program. Her story shows how patient advocates can help shape the future of #lungcancer research. Read her story: bit.ly/4unaImq

🫁 Read expert commentary from Dr. @RRamiPorta on the surgical implications of VPI in NSCLC. Visit ILCN to dive into his insights: ilcn.org/expert-comment…

Registration & Abstract are now open for the IASLC #HT26! This year’s meeting will focus on resistance to immunotherapy, bringing together researchers and clinicians to explore the scientific mechanisms behind treatment resistance and the strategies being developed to overcome it. Register now: bit.ly/3OJcCOf

Today on #InternationalWomensDay, we celebrate the women across the global thoracic oncology community who are making a difference every day. Clinicians, researchers, nurses, advocates, patients, and caregivers, your leadership and resilience continue to move the field forward. #IASLC #WomenInScience #LungCancer

🇫🇷 New Lung Cancer Considered episode in French @Alfdoc2 moderates a Virtual Tumor Board with Dr. Angela Botticella and Dr. Jean Yannis Perentes discussing management of resectable EGFR-mutant NSCLC. Listen here: bit.ly/4cxLdZs

We're excited to announce a new membership model designed for every role in thoracic oncology! 🔬 Full Member – All-access benefits, deepest conference discounts, JTO access & leadership opportunities 🎓 Associate Member – Education resources, Thoracic Circle & conference discounts 📬 Subscriber – Free updates from IASLC Explore the option that’s right for you and connect with the global thoracic oncology community. Learn more: bit.ly/4s2OeG8

Looking for support to attend #WCLC26 in Seoul? Explore IASLC opportunities open now: 🔹Early Career Education Awards 🔹Developing Countries Awards 🔹Nurse/Allied Health Awards 🔹Tobacco Control Awards 🔹IASLC Mentorship Program 🔹Reviewer Workshop 🔹Patient Advocate Awards. Learn more & apply: wclc.iaslc.org/awards/

The STARS (Supportive Training for Advocates on Research & Science) programme is open for applications until March 12th. There are two programmes open: (i) PRA (Patient Research Advocate) and (ii) Scholar. Find out more 👉iaslc-stars.org/stars-program #lcsm @IASLC

#LungCancerConsidered Dr. @StephenVLiu is joined by @sara_pilotto & Dr. Jonathan Riess to tackle a complex case of metastatic EGFR exon 19 NSCLC with discordant biomarkers & brain metastases. - Osimertinib vs FLAURA2 - CNS considerations - MARIPOSA & sequencing at progression Listen now: bit.ly/4ridnLO #LungCancer #EGFR #NSCLC